(Q30905068)

27 June 2017

title

TH1 and TH2 cytokine inhibition by 3,5-bis(trifluoromethyl)pyrazoles, a novel class of immunomodulators (English)

1 reference

27 June 2017

Yung- Wu Chen

1

1 reference

27 June 2017

Morey L Smith

2

1 reference

27 June 2017

Grace X Chiou

3

1 reference

27 June 2017

Stephen Ballaron

4

1 reference

27 June 2017

Michael P Sheets

5

1 reference

27 June 2017

Earl Gubbins

6

1 reference

27 June 2017

Usha Warrior

7

1 reference

27 June 2017

Julie Wilkins

8

1 reference

27 June 2017

Carol Surowy

9

1 reference

27 June 2017

Masaki Nakane

10

1 reference

27 June 2017

George W Carter

11

1 reference

27 June 2017

James M Trevillyan

12

1 reference

27 June 2017

Karl Mollison

13

1 reference

27 June 2017

Stevan W Djuric

14

1 reference

27 June 2017

publication date

1 December 2002

1 reference

27 June 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Cellular Immunology

1 reference

27 June 2017

volume

220

1 reference

27 June 2017

issue

2

1 reference

27 June 2017

page(s)

134-142

1 reference

FK-506 and cyclosporin A: immunosuppressive mechanism of action and beyond

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900005-4

Mechanisms of action of new immunosuppressive drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900005-4

Use of FK506 immunosuppressive therapy in pancreas transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900005-4

Tacrolimus (FK-506) in kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900005-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900005-4

Immunosuppressants: tools to investigate the physiological role of cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900005-4

Current opinions on therapeutic drug monitoring of immunosuppressive drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900005-4

Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900005-4

Monitoring of tacrolimus as rescue therapy in pediatric liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900005-4

3,5-Bis(trifluoromethyl)pyrazoles: a novel class of NFAT transcription factor regulator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900005-4

Potent inhibition of NFAT activation and T cell cytokine production by novel low molecular weight pyrazole compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900005-4

Inhibition of T lymphocyte activation by a novel p56lck tyrosine kinase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900005-4

Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2803%2900005-4

10.1016/S0008-8749(03)00005-4

7 January 2021

Identifiers

DOI

1 reference

27 June 2017

1 reference